NFE2L2 and Parkinson disease: Activations of Nrf2 by chemical modulators or genetic manipulations are demonstrated to alleviate PD-related agents, such as MPP+, Rotenone, and H2O2, as well as genetic factors induced DA neuron loss in vitro and in vivo [17].